Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio.
US RNAi therapeutics company Alnylam Pharmaceuticals (Nasdaq: ALNY) announced the US Food and Drug Administration (FDA) approval of the supplemental New Drug Application (sNDA) for its RNAi ...
1d
Investor's Business Daily on MSNAlnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBioAlnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.
2d
The Infatuation on MSNAre These TikTok-Famous LA Spots Worth The Hype?Some LA restaurants that gain traction on TikTok appear to have more style than substance. Their hype tends to be based on ...
As Mosque Road near Fraser Town sees a decline in Ramzan food business this year owing to civic work, Koramangala emerges as ...
The UPPSC will conduct the preliminary exam for the Review Officer (RO) and Assistant Review Officer (ARO) posts on July 27, ...
Prayagraj: The UP Board authorities have decided to award full marks (5) for a question in the Intermediate mathematics paper ...
SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers ...
Eugene "Big U" Henley helped launch Nipsey Hussle's career and was called rap's godfather by Wiz Khalifa. Now federal ...
A long-planned “quick-build” bike lane on Oak Street suffered a slowdown, but now it is back on the table. Pending final approval, the San Francisco Municipal Transportation Authority is ...
The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes. Patients were identified from May to December 2024 with two in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results